James P. Gregson
8Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Nov 26, 2008 → Jul 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8552154B2 | Anti-PD-L1 antibodies and uses therefor | Emerging Cross-Sectional Technologies | 189 | Active |
| US9102727B2 | Human anti-PD-1 antibodies and uses therefor | Emerging Cross-Sectional Technologies | 61 | Active |
| US10011656B2 | Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor | Emerging Cross-Sectional Technologies | 11 | Active |
| US9932402B2 | Humanized antibodies to iNKT | Chemistry; Metallurgy | 2 | Active |
| US7931899B2 | Humanized anti-amyloid beta antibodies | Chemistry; Metallurgy | 2 | Active |
| US10370448B2 | Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor | Emerging Cross-Sectional Technologies | 1 | Active |
| US8614298B2 | Humanized anti-amyloid beta antibodies | Chemistry; Metallurgy | 0 | Active |
| US11261251B2 | Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.